Revance Therapeutics, Inc. Quarterly Inventory, Net in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Revance Therapeutics, Inc. quarterly Inventory, Net history and growth rate from Q4 2019 to Q3 2024.
  • Revance Therapeutics, Inc. Inventory, Net for the quarter ending September 30, 2024 was $85.2M, a 84.4% increase year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $85.2M +$39M +84.4% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $68.3M +$33.8M +98.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $50.3M +$22.5M +81% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $45.6M +$27.3M +149% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $46.2M +$29M +169% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $34.4M +$20.8M +153% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $27.8M +$17.1M +161% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $18.3M +$8.17M +80.5% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $17.2M +$6.99M +68.5% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $13.6M +$8.54M +169% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $10.7M +$5.03M +89.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $10.2M +$4.28M +72.8% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $10.2M +$6.22M +156% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $5.07M +$4.29M +551% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $5.63M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $5.88M +$5.88M Dec 31, 2020 10-K 2022-02-28
Q3 2020 $3.98M Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $778K Jun 30, 2020 10-Q 2020-08-06
Q4 2019 $0 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.